The Beijing Economic and Technological Development Area (BDA) has constantly streamlined administration to solve corporate difficulties and optimize the business environment.

A view of the BDA [Photo/kfqgw.beijing.gov.cn]

"Having formally submitted an IPO application to the Hong Kong Stock Exchange, Acotec is expected to be listed this year. We feel really grateful for the BDA's support," said the leader of Acotec Medical Technology Co., Ltd., excitedly.

Last June, at a business symposium in the BDA, Acotec put forward a number of suggestions and demands on market expansion and the configuration of upstream and downstream industrial chains. 

The leader of Acotec mentioned that the company has received an order valued at 2 billion yuan ($306.4 million), but current production scale cannot meet the order demand. 

Therefore, the company is eager to expand production in an independent BDA park in.

After receiving the request, BDA's Administrative Examination and Approval Bureau and the Business Cooperation Bureau immediately visited Acotec. 

After multiple rounds of site selection, the plan for the expansion project was finalized, and the signing of the zone entry agreement was completed in March 2021. Acotec is now officially settled in the original Amcor plant project of the urban renewal project.

The company plans to go public in Hong Kong, but due to a lack of listing experience, it hopes that BDA's relevant departments can offer some guidance. 

Based on the experience of serving listed companies, BDA's Administrative Examination and Approval Bureau and the Business Cooperation Bureau connected with SinoCellTech Engineering Co., Ltd. to train Acotec in how to become listed.

When a company submits an IPO, it needs to apply for tax compliance, industrial and commercial compliance, and compliance at the commission of commerce.

With the coordination of various departments, it only took two weeks for Acotec to get all the approvals.